263 related articles for article (PubMed ID: 30303710)
21. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
[TBL] [Abstract][Full Text] [Related]
22. Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus.
Bonakdaran S; Hami M; Shakeri MT
Iran J Kidney Dis; 2011 Jan; 5(1):21-4. PubMed ID: 21189429
[TBL] [Abstract][Full Text] [Related]
23. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
24. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
Kacso IM; Kacso G
Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
[TBL] [Abstract][Full Text] [Related]
25. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
[TBL] [Abstract][Full Text] [Related]
26. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
27. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor activation with calcitriol for reducing urinary angiotensinogen in patients with type 2 diabetic chronic kidney disease.
Tiryaki Ö; Usalan C; Sayiner ZA
Ren Fail; 2016; 38(2):222-7. PubMed ID: 26707134
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
30. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
Ji E; Kim YS
Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
[TBL] [Abstract][Full Text] [Related]
32. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
33. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
[TBL] [Abstract][Full Text] [Related]
34. [Role of circulating angiogenic factors in diabetic kidney disease].
Martynov SA; Shestakova MV; Kutyrina IM; Il'in AV; Arbuzova MI; Dedov II
Vestn Ross Akad Med Nauk; 2013; (2):35-42. PubMed ID: 23819327
[TBL] [Abstract][Full Text] [Related]
35. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
36. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
[TBL] [Abstract][Full Text] [Related]
37. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
38. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
[TBL] [Abstract][Full Text] [Related]
39. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan.
Tseng CH
Kidney Int; 2005 Aug; 68(2):796-801. PubMed ID: 16014058
[TBL] [Abstract][Full Text] [Related]
40. A nomogram for predicting the risk of new-onset albuminuria based on baseline urinary ACR, orosomucoid, and HbA1c in patients with type 2 diabetes.
Xu Y; Shan X; Wang H
J Diabetes Complications; 2021 Dec; 35(12):108058. PubMed ID: 34635404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
